Investigative Medicine Division
We aim to rapidly translate innovative science into patient benefit across a range of disease areas. From molecular biology and target discovery, through to interventional medicine and informing policy, we bring together researchers in a diverse range of specialties including acute stroke, dementia and immunology.
Harnessing the potential of data-driven strategies to optimise transfusion practice.
Evans HG. et al, (2023), Br J Haematol
Response to "Letter to the Editor for 'Hypertonic Saline Versus Other Intracranial-Pressure-Lowering Agents for Patients with Acute Traumatic Brain Injury: A Systematic Review and Meta-analysis'".
Bernhardt K. et al, (2023), Neurocrit Care
Challenges associated with using extracellular vesicles as biomarkers in neurodegenerative disease
COUCH Y., (2023), Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare
Grieving multiple losses: Experiences of intimacy and sexuality of people living with inflammatory bowel disease. A phenomenological study.
Fourie S. et al, (2023), J Adv Nurs
Cellular iron governs the host response to malaria.
Wideman SK. et al, (2023), PLoS Pathog, 19
6 July 2022
Up to $30 million in funding has been announced by the Coalition for Epidemic Preparedness Innovations (CEPI) to bring a new nanoparticle vaccine offering protection against a range of coronaviruses to clinical trial.
Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease
1 December 2021
Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.
19 January 2023
Bones were thought to lack lymphatic vessels, but new research from the Kusumbe Group published in Cell not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.